Spotlight on Research

Roy N. Alcalay, M.D.
"Why do some people who carry genetic mutations associated with Parkinson’s disease (PD) never develop PD while others do?" asks Roy N. Alcalay, M.D., a postdoctoral fellow at the Center for Parkinson’s Disease and Other Movement Disorders...
Find a Clinical Trial
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.
PDF's targeted PubMed search provides you with access to journal articles from the last 90 days that may be pertinent to Parkinson's disease research.
Not what you're looking for? Do you need informational publications about Parkinson's targeted for people living with Parkinson's, caregivers and family members? Please browse PDF's educational materials and programs - which are all available electronically or in print. Order for yourself, a loved one or in bulk for your patients or support group.
Toxicol Appl Pharmacol 2009 Jul;
Authors: Dejan Milatovic, Snjezana Zaja-Milatovic, Ramesh C Gupta, Yingchun Yu, Michael Aschner
Vanderbilt University School of Medicine, Department of Pediatrics, Nashville, TN, USA.
Exposure to excessive manganese (Mn) levels results in neurotoxicity to the extrapyramidal system and the development of Parkinson's disease (PD)-like movement disorder, referred to as manganism. Although the mechanisms by which Mn induces neuronal damage are not well defined, its neurotoxicity appears to be regulated by a number of factors, including oxidative injury, mitochondrial dysfunction and neuroinflammation. To investigate the mechanisms underlying Mn neurotoxicity, we studied the effects of Mn on reactive oxygen species (ROS) formation, changes in high-energy phosphates (HEP), neuroinflammation mediators and associated neuronal dysfunctions both in vitro and in vivo. Primary cortical neuronal cultures showed concentration-dependent alterations in biomarkers of oxidative damage, F(2)-isoprostanes (F(2)-IsoPs) and mitochondrial dysfunction (ATP), as early as 2 hours following Mn exposure. Treatment of neurons with 500 muM Mn also resulted in time-dependent increases in the levels of the inflammatory biomarker, prostaglandin E(2) (PGE(2)). In vivo analyses corroborated these findings, establishing that either a single or three (100 mg/kg, s.c.) Mn injections (days 1, 4 and 7) induced significant increases in F(2)-IsoPs and PGE(2) in adult mouse brain 24 hours following the last injection. Quantitative morphometric analyses of Golgi-impregnated striatal sections from mice exposed to single or three Mn injections revealed progressive spine degeneration and dendritic damage of medium spiny neurons (MSNs). These findings suggest that oxidative stress, mitochondrial dysfunction and neuroinflammation are underlying mechanisms in Mn-induced neurodegeneration.
PMID: 19607852 [PubMed - as supplied by publisher]










